Aspirin or P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention for Acute Coronary Syndromes
In patients with ACS undergoing PCI, the benefits of short DAPT varied according to the subsequent monotherapy administered, with P2Y<sub>12</sub> inhibitor monotherapy significantly reducing NACE, any bleeding, and major bleeding, whereas aspirin monotherapy had neutral results. (Dual Antiplatelet Therapy De-Escalation Followed By Aspirin or P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention for Acute Coronary Syndrome: a Systematic Review and Meta-analysis; CRD42025645844).
Authors
- Luis Ortega‐Paz (ORCID: https://orcid.org/0000-0002-9567-3253)
- Antonio Greco (ORCID: https://orcid.org/0000-0002-4824-9871)
- Mattia Galli (ORCID: https://orcid.org/0009-0000-1572-718X)
- Claudio Laudani (ORCID: https://orcid.org/0000-0001-5467-7402)
- G. Occhipinti (ORCID: https://orcid.org/0000-0001-9323-3185)
- Francesco Costa (ORCID: https://orcid.org/0000-0002-5191-9477)
- Marco Spagnolo (ORCID: https://orcid.org/0000-0002-5434-607X)
- Daniele Giacoppo (ORCID: https://orcid.org/0000-0001-9008-3011)
- Davide Capodanno (ORCID: https://orcid.org/0000-0002-5156-7723)
- Dominick J Angiolillo
Institutions
- Twitter (United States) (US)
- University of Florida (US)
- University of Catania (IT)
- Maria Cecilia Hospital (IT)
- Centro de Investigación Biomédica en Red (ES)
- Hospital Clínic de Barcelona (ES)
- Policlinico Universitario di Catania (IT)
- Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco" (IT)
- Florida College (US)
Publication Details
- Journal
- JACC: Cardiovascular Interventions
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1016/j.jcin.2025.05.044
- Citations
- 9
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 12.49